>
Fuji Pharma Co logo

4554 - Fuji Pharma Co Share Price

¥1184 -4.0  -0.3%

Last Trade - 7:00am

Sector
Healthcare
Size
Small Cap
Market Cap £186.2m
Enterprise Value £235.3m
Revenue £220.4m
Position in Universe 1572nd / 3896
Bullish
Bearish
Unlock 4554 Revenue
Momentum
Relative Strength (%)
1m -0.57%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -19.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
31,680 34,229 35,387 37,909 36,279 33,793 34,600 36,050 +1.3%
+0.03 +4.5 +47.0 +0.6 -8.7 -30.3 +15.6 +11.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 March 2021, Fuji PharmaCo., Ltd. revenues increased 2% to Y17.28B. Net incomeapplicable to common stockholders increased from Y310M toY2.02B. Revenues reflect an increase in demand for theCompany's products and services due to favorable marketconditions. Net income benefited from SGA Expenses decreaseof 16% to Y4.98B (expense), Foreign Exchange Gains increasefrom Y0K to Y77M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4554 Revenue Unlock 4554 Revenue

Net Income

4554 Net Income Unlock 4554 Revenue

Normalised EPS

4554 Normalised EPS Unlock 4554 Revenue

PE Ratio Range

4554 PE Ratio Range Unlock 4554 Revenue

Dividend Yield Range

4554 Dividend Yield Range Unlock 4554 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4554 EPS Forecasts Unlock 4554 Revenue
Profile Summary

Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Directors
Last Annual September 30th, 2020
Last Interim March 31st, 2021
Incorporated April 1, 1965
Public Since June 22, 1995
No. of Shareholders: 5,396
No. of Employees: 1,550
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Tokyo Stock Exchange
Shares in Issue 24,286,812
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4554 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4554
Upcoming Events for 4554
Wednesday 4th August, 2021 Estimate
Q3 2021 Fuji Pharma Co Ltd Earnings Release
Wednesday 29th September, 2021
Dividend For 4554.T - 15.0000 JPY
Thursday 4th November, 2021 Estimate
Full Year 2021 Fuji Pharma Co Ltd Earnings Release
Frequently Asked Questions for Fuji Pharma Co
What is the Fuji Pharma Co share price?

As of 7:00am, shares in Fuji Pharma Co are trading at ¥1184, giving the company a market capitalisation of £186.2m. This share price information is delayed by 15 minutes.

How has the Fuji Pharma Co share price performed this year?

Shares in Fuji Pharma Co are currently trading at ¥1184 and the price has moved by -1.16% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fuji Pharma Co price has moved by -23.8% over the past year.

What are the analyst and broker recommendations for Fuji Pharma Co?

Of the analysts with advisory recommendations for Fuji Pharma Co, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Fuji Pharma Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Fuji Pharma Co next release its financial results?

Fuji Pharma Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Fuji Pharma Co dividend yield?

The Fuji Pharma Co dividend yield is 2.44% based on the trailing twelve month period.

Does Fuji Pharma Co pay a dividend?

Last year, Fuji Pharma Co paid a total dividend of 29, and it currently has a trailing dividend yield of 2.44%. Looking ahead, shares in Fuji Pharma Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01.

When does Fuji Pharma Co next pay dividends?

Fuji Pharma Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01. The historic dividend yield on Fuji Pharma Co shares is currently 2.44%.

How do I buy Fuji Pharma Co shares?

To buy shares in Fuji Pharma Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Fuji Pharma Co?

Shares in Fuji Pharma Co are currently trading at ¥1184, giving the company a market capitalisation of £186.2m.

Where are Fuji Pharma Co shares listed? Where are Fuji Pharma Co shares listed?

Here are the trading details for Fuji Pharma Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4554
What kind of share is Fuji Pharma Co?

Based on an overall assessment of its quality, value and momentum, Fuji Pharma Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Fuji Pharma Co share price forecast 2021?

Shares in Fuji Pharma Co are currently priced at ¥1184. At that level they are trading at 40.57% discount to the analyst consensus target price of 0.00.

Analysts covering Fuji Pharma Co currently have a consensus Earnings Per Share (EPS) forecast of 89.55 for the next financial year.

How can I tell whether the Fuji Pharma Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fuji Pharma Co. Over the past six months, the relative strength of its shares against the market has been -12.74%. At the current price of ¥1184, shares in Fuji Pharma Co are trading at -3.26% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Fuji Pharma Co PE Ratio?

The Fuji Pharma Co PE ratio based on its reported earnings over the past 12 months is 11.02. The shares are currently trading at ¥1184.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Fuji Pharma Co?

Fuji Pharma Co's management team is headed by:

Hirofumi Imai - CHM
Yumiko Yamazaki - MEO
Toyoyuki Kamide - MEO
Tadahiro Kozawa - IND
Takayuki Iwai - PRE
Satoru Hiromi - MDR
Atsuya Mitsuhashi - MEO
Masayuki Osawa - MEO
Seiichi Inoue - MEO
Takayuki Kasai - VPR
Shuichi Tanaka - IND
Keiji Hirai - IND
Naomi Aoyama - IND
Minesaburo Miyake - IND
Takanori Matsuo - DSL
Who are the major shareholders of Fuji Pharma Co?

Here are the top five shareholders of Fuji Pharma Co based on the size of their shareholding:

YK FJP Corporation
Percentage owned: 17.5% (4.33m shares)
Imai (Hirofumi) Individual Investor
Percentage owned: 16.37% (4.05m shares)
Arai (Noriko) Individual Investor
Percentage owned: 5.01% (1.24m shares)
Lotus Japan Holdings Co Ltd Corporation
Percentage owned: 4.92% (1.22m shares)
Imai (Michiko) Individual Investor
Percentage owned: 3.42% (846k shares)
Similar to 4554
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.